Posted by on September 4, 2023 9:19 pm
Categories: Column3

GLP-1 drugs.  Novo Nordisk makes both Ozempic, for Type 2 diabetes, and Wegovy, for weight loss. They mimic a glucagon-like peptide that regulates appetite in the brain, leaving people feeling sated for hours.

Source: George Frey/Reuters (no link)

Leave a Reply

Your email address will not be published. Required fields are marked *